{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:40:11Z","timestamp":1785526811949,"version":"3.56.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-3-002C"],"award-info":[{"award-number":["TJYXZDXK-3-002C"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-3-002C"],"award-info":[{"award-number":["TJYXZDXK-3-002C"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-3-002C"],"award-info":[{"award-number":["TJYXZDXK-3-002C"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-3-002C"],"award-info":[{"award-number":["TJYXZDXK-3-002C"]}]},{"name":"Tianjin Medical University Clinical Special Disease Research Center - Neuroendocrine Tumor Clinical Special Disease Research Center"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of cardiovascular mortality worldwide, with insulin resistance recognized as a key pathophysiological driver. While the triglyceride glucose-body mass index (TyG-BMI) has emerged as a promising insulin resistance marker, its prognostic value for ASCVD mortality outcomes requires further elucidation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study of 1,637 critically ill ASCVD patients (median age 68.3 years) from the MIMIC-IV database. The primary endpoints were 30-day and 1-year mortality, with secondary assessments of 90-day and 180-day mortality. Comprehensive statistical analyses included multivariable Cox regression, restricted cubic splines (RCSs) for nonlinearity assessment, and Kaplan-Meier survival analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      After full adjustment for potential confounders, elevated TyG-BMI showed significant inverse associations with both 30-day (HR 0.11, 95% CI 0.06\u20130.19) and 1-year mortality (HR 0.13, 95% CI 0.08\u20130.20). RCS analysis revealed a characteristic L-shaped dose-response relationship (nonlinear\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), while Kaplan-Meier curves demonstrated progressively improved survival across TyG-BMI quartiles (log-rank\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study revealed that the TyG-BMI is an independent predictor of mortality in critically ill ASCVD patients, with a distinct nonlinear protective effect. These findings support the potential clinical utility of the TyG-BMI for risk stratification in this high-risk population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-026-06022-1","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T02:36:42Z","timestamp":1780022202000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between triglyceride glucose-body mass index and all-cause mortality in critically ill patients with atherosclerotic cardiovascular diseases: a retrospective cohort study using the MIMIC-IV database"],"prefix":"10.1186","volume":"26","author":[{"given":"Yaxin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"6022_CR1","doi-asserted-by":"crossref","unstructured":"GBofCD and R2023C. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990\u20132023. J Am Coll Cardiol. 2025;86(22):2167\u2013243.","DOI":"10.1016\/j.jacc.2025.08.015"},{"issue":"1","key":"6022_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12916-022-02593-w","volume":"20","author":"J Quach","year":"2022","unstructured":"Quach J, Theou O, Godin J, Rockwood K, Kehler DS. The impact of cardiovascular health and frailty on mortality for males and females across the life course. BMC Med. 2022;20(1):394.","journal-title":"BMC Med"},{"issue":"1","key":"6022_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11883-025-01380-1","volume":"28","author":"J Munjas","year":"2025","unstructured":"Munjas J, Vladimirov S, Ratkovic T, et al. Toward Precision Medicine in Atherosclerotic Cardiovascular Disease: Insights from Omics Data into Sex Differences. Curr Atheroscler Rep. 2025;28(1):5.","journal-title":"Curr Atheroscler Rep"},{"issue":"10440","key":"6022_CR4","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","volume":"403","author":"GBD 2021 Causes of Death Collaborators","year":"2024","unstructured":"GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2100\u201332. https:\/\/doi.org\/10.1016\/S0140-6736(24)00367-2.","journal-title":"Lancet"},{"issue":"2","key":"6022_CR5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jcmg.2025.10.020","volume":"19","author":"M Naghavi","year":"2026","unstructured":"Naghavi M, Wong ND, McConnell MV, et al. Coronary Artery Calcium (CAC) Imaging as a Diagnostic Test: Insurance Coverage Implications. JACC Cardiovasc Imaging. 2026;19(2):266\u201373.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"19","key":"6022_CR6","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1161\/CIRCULATIONAHA.116.021314","volume":"134","author":"L Kaasenbrood","year":"2016","unstructured":"Kaasenbrood L, Boekholdt SM, van der Graaf Y, et al. Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention Population. Circulation. 2016;134(19):1419\u201329. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.021314.","journal-title":"Circulation"},{"issue":"1","key":"6022_CR7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","volume":"17","author":"V Ormazabal","year":"2018","unstructured":"Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zu\u00f1iga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122. https:\/\/doi.org\/10.1186\/s12933-018-0762-4.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"6022_CR8","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s40618-022-01925-0","volume":"46","author":"Z Wu","year":"2023","unstructured":"Wu Z, Cui H, Zhang Y, et al. The impact of the metabolic score for insulin resistance on cardiovascular disease: a 10-year follow-up cohort study. J Endocrinol Invest. 2023;46(3):523\u201333. https:\/\/doi.org\/10.1007\/s40618-022-01925-0.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"6022_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12933-024-02240-z","volume":"23","author":"D Rokicka","year":"2024","unstructured":"Rokicka D, Hudzik B, Wr\u00f3bel M, et al. The prognostic impact of insulin resistance surrogates in patients with acute myocardial infarction with and without type 2 diabetes. Cardiovasc Diabetol. 2024;23(1):147. https:\/\/doi.org\/10.1186\/s12933-024-02240-z.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"6022_CR10","doi-asserted-by":"publisher","first-page":"E214","DOI":"10.1152\/ajpendo.1979.237.3.E214","volume":"237","author":"RA DeFronzo","year":"1979","unstructured":"DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237(3):E214\u2013223. https:\/\/doi.org\/10.1152\/ajpendo.1979.237.3.E214.","journal-title":"Am J Physiol"},{"issue":"1","key":"6022_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/s12933-024-02511-9","volume":"23","author":"C Duan","year":"2024","unstructured":"Duan C, Lyu M, Shi J, Shou X, Zhao L, Hu Y. Associations of baseline and changes in the triglyceride glucose-weight adjusted waist index and cardiovascular disease risk: evidence from middle-aged and older individuals. Cardiovasc Diabetol. 2024;23(1):415. https:\/\/doi.org\/10.1186\/s12933-024-02511-9.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"6022_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12933-024-02336-6","volume":"23","author":"Q Ren","year":"2024","unstructured":"Ren Q, Huang Y, Liu Q, Chu T, Li G, Wu Z. Association between triglyceride glucose-waist height ratio index and cardiovascular disease in middle-aged and older Chinese individuals: a nationwide cohort study. Cardiovasc Diabetol. 2024;23(1):247. https:\/\/doi.org\/10.1186\/s12933-024-02336-6.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"6022_CR13","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12933-025-02675-y","volume":"24","author":"D Mo","year":"2025","unstructured":"Mo D, Zhang P, Zhang M, Dai H, Guan J. Cholesterol, high-density lipoprotein, and glucose index versus triglyceride-glucose index in predicting cardiovascular disease risk: a cohort study. Cardiovasc Diabetol. 2025;24(1):116. https:\/\/doi.org\/10.1186\/s12933-025-02675-y.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"6022_CR14","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1186\/s12889-025-22018-6","volume":"25","author":"B Chen","year":"2025","unstructured":"Chen B, Wang H, Xu S, et al. Association between the triglyceride glucose-body mass index and mortality risk in cardiovascular disease populations: a longitudinal cohort study. BMC Public Health. 2025;25(1):822. https:\/\/doi.org\/10.1186\/s12889-025-22018-6.","journal-title":"BMC Public Health"},{"key":"6022_CR15","doi-asserted-by":"publisher","first-page":"1529004","DOI":"10.3389\/fendo.2025.1529004","volume":"16","author":"Y Sun","year":"2025","unstructured":"Sun Y, Hu Y. Association of triglyceride-glucose-body mass index with all-cause mortality among individuals with cardiovascular disease: results from NHANES. Front Endocrinol (Lausanne). 2025;16:1529004. https:\/\/doi.org\/10.3389\/fendo.2025.1529004.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"6022_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12933-023-02114-w","volume":"23","author":"F Li","year":"2024","unstructured":"Li F, Wang Y, Shi B, et al. Association between the cumulative average triglyceride glucose-body mass index and cardiovascular disease incidence among the middle-aged and older population: a prospective nationwide cohort study in China. Cardiovasc Diabetol. 2024;23(1):16. https:\/\/doi.org\/10.1186\/s12933-023-02114-w.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"6022_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","volume":"10","author":"AEW Johnson","year":"2023","unstructured":"Johnson AEW, Bulgarelli L, Shen L, et al. MIMIC-IV, a freely accessible electronic health record dataset. Sci Data. 2023;10(1):1.","journal-title":"Sci Data"},{"issue":"1","key":"6022_CR18","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/S2666-7568(22)00247-1","volume":"4","author":"P Lopez-Jaramillo","year":"2023","unstructured":"Lopez-Jaramillo P, Gomez-Arbelaez D, Martinez-Bello D, et al. Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study. Lancet Healthy Longev. 2023;4(1):e23\u201333. https:\/\/doi.org\/10.1016\/S2666-7568(22)00247-1.","journal-title":"Lancet Healthy Longev"},{"issue":"1","key":"6022_CR19","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12933-024-02290-3","volume":"23","author":"X Xia","year":"2024","unstructured":"Xia X, Chen S, Tian X, et al. Association of triglyceride-glucose index and its related parameters with atherosclerotic cardiovascular disease: evidence from a 15-year follow-up of Kailuan cohort. Cardiovasc Diabetol. 2024;23(1):208. https:\/\/doi.org\/10.1186\/s12933-024-02290-3.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"6022_CR20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12933-025-02672-1","volume":"24","author":"S Tao","year":"2025","unstructured":"Tao S, Yu L, Li J, et al. Insulin resistance quantified by estimated glucose disposal rate predicts cardiovascular disease incidence: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):161. https:\/\/doi.org\/10.1186\/s12933-025-02672-1.","journal-title":"Cardiovasc Diabetol"},{"key":"6022_CR21","doi-asserted-by":"publisher","first-page":"1479980","DOI":"10.3389\/fendo.2024.1479980","volume":"15","author":"X Su","year":"2024","unstructured":"Su X, Rao H, Zhao C, Zhang X, Li D. The association between the metabolic score for insulin resistance and mortality in patients with cardiovascular disease: a national cohort study. Front Endocrinol (Lausanne). 2024;15:1479980. https:\/\/doi.org\/10.3389\/fendo.2024.1479980.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"6022_CR22","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1161\/ATVBAHA.123.319200","volume":"43","author":"JH Lee","year":"2023","unstructured":"Lee JH, Jeon S, Joung B, Lee HS, Kwon YJ. Associations of Homeostatic Model Assessment for Insulin Resistance Trajectories With Cardiovascular Disease Incidence and Mortality. Arterioscler Thromb Vasc Biol. 2023;43(9):1719\u201328. https:\/\/doi.org\/10.1161\/ATVBAHA.123.319200.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"6022_CR23","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12933-024-02249-4","volume":"23","author":"Q Hou","year":"2024","unstructured":"Hou Q, Qi Q, Han Q, et al. Association of the triglyceride-glucose index with early-onset atherosclerotic cardiovascular disease events and all-cause mortality: a prospective cohort study. Cardiovasc Diabetol. 2024;23(1):149. https:\/\/doi.org\/10.1186\/s12933-024-02249-4.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"6022_CR24","doi-asserted-by":"publisher","first-page":"e0149731","DOI":"10.1371\/journal.pone.0149731","volume":"11","author":"LK Er","year":"2016","unstructured":"Er LK, Wu S, Chou HH, et al. Triglyceride Glucose-Body Mass Index Is a Simple and Clinically Useful Surrogate Marker for Insulin Resistance in Nondiabetic Individuals. PLoS ONE. 2016;11(3):e0149731. https:\/\/doi.org\/10.1371\/journal.pone.0149731.","journal-title":"PLoS ONE"},{"key":"6022_CR25","doi-asserted-by":"publisher","first-page":"1399969","DOI":"10.3389\/fnut.2024.1399969","volume":"11","author":"C Luo","year":"2024","unstructured":"Luo C, Li Q, Wang Z, Duan S, Ma Q. Association between triglyceride glucose-body mass index and all-cause mortality in critically ill patients with acute myocardial infarction: retrospective analysis of the MIMIC-IV database. Front Nutr. 2024;11:1399969. https:\/\/doi.org\/10.3389\/fnut.2024.1399969.","journal-title":"Front Nutr"},{"issue":"1","key":"6022_CR26","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s12877-024-04992-5","volume":"24","author":"L Ding","year":"2024","unstructured":"Ding L, Fu B, Zhang H, et al. The impact of triglyceride glucose-body mass index on all-cause and cardiovascular mortality in elderly patients with diabetes mellitus: evidence from NHANES 2007\u20132016. BMC Geriatr. 2024;24(1):356. https:\/\/doi.org\/10.1186\/s12877-024-04992-5.","journal-title":"BMC Geriatr"},{"key":"6022_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.pcad.2022.11.013","volume":"78","author":"AW Tutor","year":"2023","unstructured":"Tutor AW, Lavie CJ, Kachur S, Milani RV, Ventura HO. Updates on obesity and the obesity paradox in cardiovascular diseases. Prog Cardiovasc Dis. 2023;78:2\u201310. https:\/\/doi.org\/10.1016\/j.pcad.2022.11.013.","journal-title":"Prog Cardiovasc Dis"},{"issue":"6","key":"6022_CR28","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.nut.2011.10.006","volume":"28","author":"A Casas-Vara","year":"2012","unstructured":"Casas-Vara A, Santolaria F, Fern\u00e1ndez-Bereciart\u00faa A, Gonz\u00e1lez-Reimers E, Garc\u00eda-Ochoa A, Mart\u00ednez-Riera A. The obesity paradox in elderly patients with heart failure: analysis of nutritional status. Nutrition. 2012;28(6):616\u201322. https:\/\/doi.org\/10.1016\/j.nut.2011.10.006.","journal-title":"Nutrition"},{"issue":"11","key":"6022_CR29","doi-asserted-by":"publisher","first-page":"e024143","DOI":"10.1161\/JAHA.121.024143","volume":"11","author":"W Kwon","year":"2022","unstructured":"Kwon W, Lee SH, Yang JH, et al. Impact of the Obesity Paradox Between Sexes on In-Hospital Mortality in Cardiogenic Shock: A Retrospective Cohort Study. J Am Heart Assoc. 2022;11(11):e024143. https:\/\/doi.org\/10.1161\/JAHA.121.024143.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"6022_CR30","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41467-019-08607-1","volume":"10","author":"IC Furigo","year":"2019","unstructured":"Furigo IC, Teixeira PDS, de Souza GO, et al. Growth hormone regulates neuroendocrine responses to weight loss via AgRP neurons. Nat Commun. 2019;10(1):662. https:\/\/doi.org\/10.1038\/s41467-019-08607-1.","journal-title":"Nat Commun"},{"key":"6022_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-48382-5_1","volume":"960","author":"A Engin","year":"2017","unstructured":"Engin A. The Definition and Prevalence of Obesity and Metabolic Syndrome. Adv Exp Med Biol. 2017;960:1\u201317. https:\/\/doi.org\/10.1007\/978-3-319-48382-5_1.","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"6022_CR32","doi-asserted-by":"publisher","first-page":"610","DOI":"10.7326\/M14-1551","volume":"162","author":"P Costanzo","year":"2015","unstructured":"Costanzo P, Cleland JGF, Pellicori P, et al. The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study. Ann Intern Med. 2015;162(9):610\u20138. https:\/\/doi.org\/10.7326\/M14-1551.","journal-title":"Ann Intern Med"},{"key":"6022_CR33","doi-asserted-by":"publisher","unstructured":"Kwok MK, Lee SY, Leung GM, Schooling CM. Body mass index trajectories and all-cause mortality in older Chinese adults: Hong Kong\u2019s Elderly Health Service Cohort. J Epidemiol Community Health. Published online March 26, 2025:jech-2025-223659. https:\/\/doi.org\/10.1136\/jech-2025-223659","DOI":"10.1136\/jech-2025-223659"},{"issue":"1","key":"6022_CR34","doi-asserted-by":"publisher","first-page":"7963","DOI":"10.1038\/s41598-025-92860-6","volume":"15","author":"B Xie","year":"2025","unstructured":"Xie B, Liu B, Chen X, et al. ALM adjusted by BMI or weight predicts adverse health outcomes in middle-aged and elderly patients with type 2 diabetes. Sci Rep. 2025;15(1):7963. https:\/\/doi.org\/10.1038\/s41598-025-92860-6.","journal-title":"Sci Rep"},{"issue":"1","key":"6022_CR35","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13098-024-01538-y","volume":"16","author":"J Tian","year":"2024","unstructured":"Tian J, Jin K, Qian H, Xu H. Impact of the obesity paradox on 28-d mortality in elderly patients critically ill with cardiogenic shock: a retrospective cohort study. Diabetol Metab Syndr. 2024;16(1):292. https:\/\/doi.org\/10.1186\/s13098-024-01538-y.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"6022_CR36","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s40001-024-01962-w","volume":"29","author":"D Xu","year":"2024","unstructured":"Xu D, Lu Y, Wang Y, Li F. The obesity paradox and 90\u00a0day mortality in chronic critically ill patients: a cohort study using a large clinical database. Eur J Med Res. 2024;29(1):392. https:\/\/doi.org\/10.1186\/s40001-024-01962-w.","journal-title":"Eur J Med Res"},{"issue":"1","key":"6022_CR37","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13054-022-04074-1","volume":"26","author":"D Zhou","year":"2022","unstructured":"Zhou D, Wang C, Lin Q, Li T. The obesity paradox for survivors of critically ill patients. Crit Care. 2022;26(1):198. https:\/\/doi.org\/10.1186\/s13054-022-04074-1.","journal-title":"Crit Care"},{"issue":"4","key":"6022_CR38","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/CCM.0000000000005788","volume":"51","author":"CA den Uil","year":"2023","unstructured":"den Uil CA, Termorshuizen F, Rietdijk WJR, et al. Age Moderates the Effect of Obesity on Mortality Risk in Critically Ill Patients With COVID-19: A Nationwide Observational Cohort Study. Crit Care Med. 2023;51(4):484\u201391. https:\/\/doi.org\/10.1097\/CCM.0000000000005788.","journal-title":"Crit Care Med"},{"issue":"4","key":"6022_CR39","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/SHK.0000000000000512","volume":"45","author":"PN Mittwede","year":"2016","unstructured":"Mittwede PN, Clemmer JS, Bergin PF, Xiang L. OBESITY AND CRITICAL ILLNESS: INSIGHTS FROM ANIMAL MODELS. Shock. 2016;45(4):349\u201358. https:\/\/doi.org\/10.1097\/SHK.0000000000000512.","journal-title":"Shock"},{"issue":"3","key":"6022_CR40","doi-asserted-by":"publisher","first-page":"R122","DOI":"10.1186\/cc12794","volume":"17","author":"P Wacharasint","year":"2013","unstructured":"Wacharasint P, Boyd JH, Russell JA, Walley KR. One size does not fit all in severe infection: obesity alters outcome, susceptibility, treatment, and inflammatory response. Crit Care. 2013;17(3):R122. https:\/\/doi.org\/10.1186\/cc12794.","journal-title":"Crit Care"},{"issue":"1","key":"6022_CR41","first-page":"66","volume":"109","author":"I Grigora\u015f","year":"2014","unstructured":"Grigora\u015f I, Branisteanu DD, Ungureanu D, Rusu D, Ristescu I. Early dynamics of leptin plasma level in surgical critically ill patients. a prospective comparative study. Chirurgia (Bucur). 2014;109(1):66\u201372.","journal-title":"Chirurgia (Bucur)"},{"issue":"4","key":"6022_CR42","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3109\/10409238.2012.694843","volume":"47","author":"NS Kalupahana","year":"2012","unstructured":"Kalupahana NS, Moustaid-Moussa N. The adipose tissue renin-angiotensin system and metabolic disorders: a review of molecular mechanisms. Crit Rev Biochem Mol Biol. 2012;47(4):379\u201390. https:\/\/doi.org\/10.3109\/10409238.2012.694843.","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"12","key":"6022_CR43","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1007\/s00134-020-06310-0","volume":"46","author":"P Vignon","year":"2020","unstructured":"Vignon P, Evrard B, Asfar P, et al. Fluid administration and monitoring in ARDS: which management? Intensive Care Med. 2020;46(12):2252\u201364. https:\/\/doi.org\/10.1007\/s00134-020-06310-0.","journal-title":"Intensive Care Med"},{"key":"6022_CR44","doi-asserted-by":"publisher","first-page":"111879","DOI":"10.1016\/j.nut.2022.111879","volume":"105","author":"J Zhang","year":"2023","unstructured":"Zhang J, Du L, Jin X, et al. Association between body mass index change and mortality in critically ill patients: A retrospective observational study. Nutrition. 2023;105:111879. https:\/\/doi.org\/10.1016\/j.nut.2022.111879.","journal-title":"Nutrition"},{"issue":"1","key":"6022_CR45","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s12933-024-02436-3","volume":"23","author":"P Valensi","year":"2024","unstructured":"Valensi P. Evidence of a bi-directional relationship between heart failure and diabetes: a strategy for the detection of glucose abnormalities and diabetes prevention in patients with heart failure. Cardiovasc Diabetol. 2024;23(1):354. https:\/\/doi.org\/10.1186\/s12933-024-02436-3.","journal-title":"Cardiovasc Diabetol"},{"key":"6022_CR46","doi-asserted-by":"publisher","unstructured":"Kantharia BK, Tabary M, Wu L, et al. Diabetes and Atrial Fibrillation: Insight From Basic to Translational Science Into the Mechanisms and Management. J Cardiovasc Electrophysiol Published online April. 2025;1. https:\/\/doi.org\/10.1111\/jce.16655.","DOI":"10.1111\/jce.16655"},{"issue":"5","key":"6022_CR47","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.3390\/biomedicines12051098","volume":"12","author":"R Jha","year":"2024","unstructured":"Jha R, Lopez-Trevino S, Kankanamalage HR, Jha JC. Diabetes and Renal Complications: An Overview on Pathophysiology, Biomarkers and Therapeutic Interventions. Biomedicines. 2024;12(5):1098. https:\/\/doi.org\/10.3390\/biomedicines12051098.","journal-title":"Biomedicines"},{"key":"6022_CR48","doi-asserted-by":"publisher","first-page":"102308","DOI":"10.1016\/j.pmedr.2023.102308","volume":"35","author":"Y Wang","year":"2023","unstructured":"Wang Y, Liu X, Xue T, et al. Body mass index and risk of all-cause mortality among elderly Chinese: An empirical cohort study based on CLHLS data. Prev Med Rep. 2023;35:102308. https:\/\/doi.org\/10.1016\/j.pmedr.2023.102308.","journal-title":"Prev Med Rep"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06022-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06022-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06022-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:04:01Z","timestamp":1785521041000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06022-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6022"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06022-1","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study utilized data from the MIMIC-IV database, which has received approval from the Massachusetts Institute of Technology\u2019s Institutional Review Board (IRB). As the data were fully anonymized, this research was exempt from institutional ethical review and informed consent requirements under 45 CFR 46.104(d)(4). The investigation was conducted in strict compliance with the ethical principles set forth in the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"646"}}